Personalized Medicine and Anti-EGFR Antibody Therapy in the Treatment of Metastatic Colorectal Cancer: KRAS and Beyond

被引：0
|
作者：
Chu, Edward [1 ]
机构：
[1] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15260 USA
来源：
ONCOLOGY-NEW YORK | 2014年 / 28卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：96 / 96
页数：1
相关论文
共 50 条
  • [41] Panitumumab: A new anti-EGFR antibody for the treatment of advanced colorectal cancer
    Chu, Edward
    CLINICAL COLORECTAL CANCER, 2006, 6 (01) : 13 - 13
  • [42] CEA dynamics for predicting response after anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer
    Kang, Sora
    Kim, Sun Young
    Hong, Yong Sang
    Kim, Tae Won
    Choi, Ki Eun
    Kim, Min Jung
    Kim, Jeong Eun
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [43] Clinical interest of KRAS mutation detection in blood for anti-EGFR therapies in metastatic colorectal cancer
    F Di Fiore
    F Charbonnier
    B Lefebure
    M Laurent
    F Le Pessot
    P Michel
    T Frebourg
    British Journal of Cancer, 2008, 99 : 551 - 552
  • [44] Anti-Metastatic Activity of an Anti-EGFR Monoclonal Antibody against Metastatic Colorectal Cancer with KRAS p.G13D Mutation
    Ohishi, Tomokazu
    Kato, Yukinari
    Kaneko, Mika K.
    Ohba, Shun-ichi
    Inoue, Hiroyuki
    Harakawa, Akiko
    Kawada, Manabu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (17) : 1 - 16
  • [45] KRAS Mutation Testing of Colorectal Cancer for Anti-EGFR Therapy: Dogmas Versus Evidence
    Timar, J.
    Hegedus, B.
    Raso, E.
    CURRENT CANCER DRUG TARGETS, 2010, 10 (08) : 813 - 823
  • [46] Review article: panitumumab - a fully human anti-EGFR monoclonal antibody for treatment of metastatic colorectal cancer
    Peeters, M.
    Balfour, J.
    Arnold, D.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (03) : 269 - 281
  • [47] Impact of genetic profiles on the efficacy of anti-EGFR antibodies in metastatic colorectal cancer with KRAS mutation
    Kishiki, Tomokazu
    Ohnishi, Hiroaki
    Masaki, Tadahiko
    Ohtsuka, Kouki
    Ohkura, Yasuo
    Furuse, Jyunji
    Sugiyama, Masanori
    Watanabe, Takashi
    ONCOLOGY REPORTS, 2014, 32 (01) : 57 - 64
  • [48] CEA dynamics for predicting response after anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer
    Sora Kang
    Sun Young Kim
    Yong Sang Hong
    Tae Won Kim
    Ki Eun Choi
    Min Jung Kim
    Jeong Eun Kim
    Scientific Reports, 13
  • [49] Clinical interest of KRAS mutation detection in blood for anti-EGFR therapies in metastatic colorectal cancer
    Di Fiore, F.
    Charbonnier, F.
    Lefebure, B.
    Laurent, M.
    Le Pessot, F.
    Michel, P.
    Frebourg, T.
    BRITISH JOURNAL OF CANCER, 2008, 99 (03) : 551 - 552
  • [50] AMPK activation overcomes anti-EGFR antibody resistance induced by KRAS mutation in colorectal cancer
    Hua Ye
    Yi Liu
    Kefeng Wu
    Hui Luo
    Liao Cui
    Cell Communication and Signaling, 18
12345